THE RESOURCE USE RELATED TO HIP FRACTURES BASED ON DATA FROM ICUROS

Author(s)

Wintzell V1;Ivergård M1;Tankó LB2;Barghout V*2;Svedbom A1;Alekna V3;Bianchi ML4;Clark P5;Díaz Curiel M6;Dimai HP7;Jürisson M8;Lesnyak O9;McCloskey E10;Sanders KM11;Thomas T12;Borgström F13, Kanis JA14 1OptumInsight, Stockholm, Sweden, 2Novartis Pharma AG, Basel, Switzerland, 3Vilnius University, Faculty of Medicine, Vilnius, Lithuania, 4Bone Metabolism Unit, Istituto Auxologico Italiano IRCCS, Milan, Italy, 5Clinical Epidemiology Unit, Hospital Infantil Federico Gómez and Faculty of Medicine UNAM, Mexico city, Mexico, 6Catedra de Enfermedades Metabolicas Óseas, Universidad Autonoma, Madrid, Spain, 7Department of Internal Medicine, Division of Endocrinology and Metabolism, Medical University of Graz, Graz, Austria, 8Faculty of Medicine, Tartu University, Tartu, Estonia, 9Ural State Medical Academy, Yekaterinburg, Russia, 10Academic Unit of Bone Metabolism, Metabolic Bone Centre, University of Sheffield, Sheffield, United Kingdom, 11Department of Medicine, NorthWest Academic Centre, The University of Melbourne, Melbourne, Australia, 12INSERM U1059, CHU-St-Etienne, Saint Etienne, France, 13LIME/MMC, Karolinska Institutet, Stockholm, Sweden, 14WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, Sheffield, United Kingdom

OBJECTIVES: The International Costs and Utilities Related to Osteoporotic fractures Study (ICUROS) is an ongoing 18 months prospective observational study with the objective of estimating resource use and health related quality of life related to osteoporotic fractures. This study aims to describe the resource utilization for hip fractures (sustained during 2007-2012) pooled from 10 countries: Australia, Austria, Estonia, France, Italy, Lithuania, Mexico, Russia, Spain, and the UK. METHODS: Patients studied were ≥ 50 years and lived at home prior to fracture. Data were collected through patient interviews and review of medical records: at baseline and 4, 12, and 18 months after fracture. Only resource use related to the fracture event was collected. RESULTS: There were 1,795, 1,435, 1,256 patients available for analysis at 4, 12 and 18 months follow-up, respectively. The mean age (±SD) at fracture was 77±10 years and 79% were women. 96% of patients were hospitalized. Mean hospital length of stay (LoS) (±SD) was 17.2±20.4 days during months 0-4 and 1.2±6.8 during months 5-18. Mean LoS varied from 9.3 days to 26.5 days during months 0-4 across countries. The mean number of physician visits (±SD) was 2.8±3.1 during months 0-4 and 2.5±5.6 between months 5-18. The mean number of nurse visits (±SD) was 2.4±9.6 and 3.8±31.9 during corresponding periods, respectively. During months 0-4, 65% of patients used analgesics, 41% calcium/vitamin D, and 27% pharmacological interventions for osteoporosis.  The respective uptakes for months 5-18 were 47%, 46% and 25%. CONCLUSIONS: Almost all patients were hospitalized after fracture and the mean number of inpatient days is high, although there is a large variation. The vast majority of health care consumption in relation to fracture occurs during the first 4 months but substantial consumption persists up to 18 months after fracture.

Conference/Value in Health Info

2013-11, ISPOR Europe 2013, The Convention Centre Dublin

Value in Health, Vol. 16, No. 7 (November 2013)

Code

PMS105

Topic

Economic Evaluation

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies

Disease

Musculoskeletal Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×